Filing Details

Accession Number:
0001181431-10-056162
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-17 12:04:39
Reporting Period:
2010-11-15
Filing Date:
2010-11-17
Accepted Time:
2010-11-17 12:04:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1040416 Inspire Pharmaceuticals Inc ISPH Pharmaceutical Preparations (2834) 043209022
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1228447 Kip Frey C/O Inspire Pharmaceuticals, Inc.
4222 Emperor Blvd., Suite 200
Durham NC 27703
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-15 7,934 $2.76 7,934 No 4 M Direct
Common Stock Disposition 2010-11-15 3,434 $7.25 4,500 No 4 S Direct
Common Stock Disposition 2010-11-15 198 $7.26 4,302 No 4 S Direct
Common Stock Disposition 2010-11-15 996 $7.27 3,306 No 4 S Direct
Common Stock Disposition 2010-11-15 2,306 $7.28 1,000 No 4 S Direct
Common Stock Disposition 2010-11-15 517 $7.33 483 No 4 S Direct
Common Stock Disposition 2010-11-15 400 $7.34 83 No 4 S Direct
Common Stock Disposition 2010-11-15 83 $7.35 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-11-15 7,934 $0.00 7,934 $2.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
32,066 2012-06-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,000 Indirect By Children
Footnotes
  1. Vested as to 30,000 shares in three equal annual installments commencing on the date of the Annual Meeting of Stockholders in 2003 for service as a director and as to 10,000 shares in three equal annual installments for service as a member of the Audit Committee.